Kenneth L. Davis's guest appearances

Kenneth L. Davis

The World According to Boyar

Elon Musk

Ryan Serhant

Mellody Hobson

Tobias Carlisle

Scott Turow

Barry Diller

Ken Langone

Frank Blake

Neil Vogel

Mario Gabelli

David Zaslav

Joey Levin

David Alpert

Howard Lorber

John Malone

OwlTail

The interview discusses: How Dr. Davis led one of the greatest financial turnarounds in medical history. The reasons why healthcare keeps becoming more expensive along with solutions on how to decrease costs without sacrificing care. Why drug pricing should be a trade issue. Why the current patent system discourages pharmaceutical innovation. What “value based” medicine is and why insurance companies and hospitals should consider adopting it. Why the National Institutes of Health is so vital to drug discovery. His thoughts on CVS’s strategy of becoming an integrated health care provider. What serious healthcare problem he sees getting worse which he believes has the potential to bankrupt the entire Medicare system. And much more….Biography: Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System, is widely recognized as a visionary leader who has guided the institution on a strong and dramatic growth trajectory. In 2013, the Mount Sinai Health System was formed by the combination of The Mount Sinai Medical Center and Continuum Health Partners, becoming one of the largest nonprofit systems in the country with $8 billion in revenue, 42,000 employees, eight hospitals, and more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Prior to becoming CEO, Dr. Davis spent 15 years as Chair of Mount Sinai’s Department of Psychiatry. He was the first Director for many of the institution’s research entities, including Mount Sinai’s National Institutes of Health (NIH)-funded Alzheimer’s Disease Research Center, the Schizophrenia Biological Research Center at the Bronx Veterans Affairs Medical Center, the Silvio Conte Neuroscience Center to study schizophrenia, and the Seaver Autism Center for Research and Treatment. Additionally, he received one of the first and largest program project grants for Alzheimer’s disease research from the NIH.The Boyar Value Group's mission is to search for value on behalf of our clients. Since 1975, the Boyar family of companies has been relentlessly focused on discovering value for our clients. For more than four decades we have navigated through fads, gimmicks and market volatility. Utilizing value investing to try to create and preserve wealth has and always will be our sole focus. Our experienced team of analysts looks for diamonds in the rough, companies passed over by the rest of the investment community, but whose true value, in our opinion, significantly exceeds their current stock price. In essence, we are trying to buy a dollar for fifty cents. To find out more about the Boyar Value Group, please visit www.boyarvaluegroup.com

The interview discusses: How Dr. Davis led one of the greatest financial turnarounds in medical history. The reasons why healthcare keeps becoming more expensive along with solutions on how to decrease costs without sacrificing care. Why drug pricing should be a trade issue. Why the current patent system discourages pharmaceutical innovation. What “value based” medicine is and why insurance companies and hospitals should consider adopting it. Why the National Institutes of Health is so vital to drug discovery. His thoughts on CVS’s strategy of becoming an integrated health care provider. What serious healthcare problem he sees getting worse which he believes has the potential to bankrupt the entire Medicare system. And much more….Biography: Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System, is widely recognized as a visionary leader who has guided the institution on a strong and dramatic growth trajectory. In 2013, the Mount Sinai Health System was formed by the combination of The Mount Sinai Medical Center and Continuum Health Partners, becoming one of the largest nonprofit systems in the country with $8 billion in revenue, 42,000 employees, eight hospitals, and more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Prior to becoming CEO, Dr. Davis spent 15 years as Chair of Mount Sinai’s Department of Psychiatry. He was the first Director for many of the institution’s research entities, including Mount Sinai’s National Institutes of Health (NIH)-funded Alzheimer’s Disease Research Center, the Schizophrenia Biological Research Center at the Bronx Veterans Affairs Medical Center, the Silvio Conte Neuroscience Center to study schizophrenia, and the Seaver Autism Center for Research and Treatment. Additionally, he received one of the first and largest program project grants for Alzheimer’s disease research from the NIH.The Boyar Value Group's mission is to search for value on behalf of our clients. Since 1975, the Boyar family of companies has been relentlessly focused on discovering value for our clients. For more than four decades we have navigated through fads, gimmicks and market volatility. Utilizing value investing to try to create and preserve wealth has and always will be our sole focus. Our experienced team of analysts looks for diamonds in the rough, companies passed over by the rest of the investment community, but whose true value, in our opinion, significantly exceeds their current stock price. In essence, we are trying to buy a dollar for fifty cents. To find out more about the Boyar Value Group, please visit <a href="http://www.boyarvaluegroup.com" rel="nofollow" target="_blank">www.boyarvaluegroup.com</a>

Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System, on how to decrease healthcare costs without sacrificing quality of care and why drug pricing should be a trade issue.